This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Kyowa Kirin Co., Ltd., The University of Toyama. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 46 
1 out of 38 
Years Active: 2019
Title: **Masashi Ikutani: Innovator in Pulmonary Hypertension Treatment**
Introduction
Masashi Ikutani is an accomplished inventor hailing from Toyama, Japan. With a focus on therapeutic advancements, he has made significant contributions to the field of medicine, particularly in treating pulmonary hypertension.
Latest Patents
Ikutani holds a notable patent titled "Method for treating pulmonary hypertension with interleukin-5 receptor antibody." This innovative therapeutic agent includes an interleukin-5 receptor (IL-5R)-inhibiting compound, aimed at offering new treatment avenues for pulmonary hypertension. The patent specifically describes an antibody or antibody fragment that can bind to the extracellular region of IL-5R, enhancing the understanding and treatment methods for this condition.
Career Highlights
Throughout his career, Masashi Ikutani has collaborated with esteemed institutions and companies, furthering his research and contributions to healthcare. He has worked at the National University Corporation University of Toyama, where he likely engaged in extensive research and development in his field. Additionally, he has contributed to Kyowa Kirin Co., Ltd., a leading biopharmaceutical company, enhancing his practical experience in innovation and patent development.
Collaborations
Ikutani has had the opportunity to work alongside notable colleagues such as Kiyoshi Takatsu and Hiromi Ehara. Collaborations with skilled professionals often lead to enriched research endeavors and advancements in treatment options, emphasizing the importance of teamwork in the innovation process.
Conclusion
Masashi Ikutani's dedication to exploring therapeutic methods for pulmonary hypertension through innovative approaches showcases the potential for advancements in medicine. His patent and collaborative efforts indicate a promising future for both his career and the patients who may benefit from his inventions. The ongoing research and applications stemming from his work serve as a testament to the critical role of inventors in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile